Pfizer to Pay Big Fine. Drug maker Pfizer, Inc. led the news with two announcements this week: It took a record-breaking hit of $2.3 billion over investigations into its improper marketing of the painkiller Bextra and other medications and it is acquiring its rival, Wyeth, for $68 billion, reported Bloomberg News. … [Read more...]
Big Fine Over Bextra Promotion
Arizona Bextra Lawsuit Charges Pfizer
Arizona Bextra Lawsuit Charges Pfizer In 2005, the U.S. Food and Drug Administration (FDA) and European regulators formally asked Pfizer, Inc. to suspend sales of Bextra in the United States and Europe. As a result, Pfizer announced it would halt sales of the drug in the United States and the European Union countries immediately. The … [Read more...]
Pfizer Bextra, Celebrex Settlement
Pfizer Bextra, Celebrex Settlement. Pfizer has reached a tentative agreement to settle lawsuits involving its Bextra and Celebrex painkillers for $894 million. If it goes forward, the Pfizer Bextra and Celebrex settlement will resolve roughly 90 percent of the personal injury lawsuits the company faces because of the … [Read more...]
Celebrex, Bextra Settlements Negotiation
Pfizer Celebrex, Bextra Settlements. Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers. It is estimated that between 7,000 and 9,000 Celebrex and Bextra cases have been filed by people who claim the defective painkillers caused heart attacks and strokes. According to a report in Friday's … [Read more...]
Life-Threatening Bextra Side Effects
Bextra Side Effects Injury Lawsuits. Pfizer Inc.'s pain pill Bextra should be kept off the market permanently because of potentially life-threatening side effects, federal regulators said Wednesday. Food and Drug Administration staff members concluded that the drug has greater health risks than similar painkillers, including … [Read more...]
Health Canada Bans Bextra Sales
Pfizer's Bextra Was Removed From The Market. The era of the COX-2 inhibitors appears to be coming to an end. Vioxx was removed from the market worldwide by Merck in September 2004. Pfizer has announced Celebrex is about to undergo new safety testing while the company’s other COX-2 inhibitor, Bextra, was removed from the market in … [Read more...]
FDA Bans Bextra Painkiller Sale
Bextra Risk Of Heart Attack And Skin Conditions. The Food and Drug Administration has followed the US FDA's lead by banning the sale of Bextra, a kind of painkiller for joint aches which puts users at risk of heart attack and skin conditions. The US FDA on April 7 asked Pfizer to withdraw ‘Bextra’ from the market and announced … [Read more...]
